FOXOD (FOXO Technologies) Ending Cash Position: $0.07 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is FOXO Technologies Ending Cash Position?

FOXO Technologies FOXOD +15.61% Ending Cash Position is $0.07 Mil as of Mar. 2026. The stock has 4 warning signs investors should review.

FOXO Technologies's Ending Cash Position for the quarter that ended in Mar. 2026 was $0.07 Mil.

FOXO Technologies's quarterly Ending Cash Position declined from Sep. 2025 ($0.63 Mil) to Dec. 2025 ($0.21 Mil) and declined from Dec. 2025 ($0.21 Mil) to Mar. 2026 ($0.07 Mil).

FOXO Technologies's annual Ending Cash Position increased from Dec. 2023 ($0.04 Mil) to Dec. 2024 ($0.07 Mil) and increased from Dec. 2024 ($0.07 Mil) to Dec. 2025 ($0.21 Mil).

FOXO Technologies Ending Cash Position Related Terms

FOXO Technologies Ending Cash Position Historical Data

* Premium members only.

The historical data trend for FOXO Technologies's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FOXO Technologies Ending Cash Position Chart

FOXO Technologies Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial 6.86 5.52 0.04 0.07 0.21

FOXO Technologies Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.32 0.63 0.21 0.07

FOXO Technologies Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

FOXO Technologies's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=0.068+0.139
=0.21

FOXO Technologies's Ending Cash Position for the quarter that ended in Mar. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=0.208+-0.142
=0.07

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of $0.07 Mil mean?
FOXO Technologies (FOXOD) has a Ending Cash Position of $0.07 Mil as of Mar. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on FOXO Technologies and its competitors.
Is FOXO Technologies' Ending Cash Position too high?
FOXO Technologies' current Ending Cash Position is $0.07 Mil.
How does FOXO Technologies' Ending Cash Position compare to NHLG and BACK?
FOXO Technologies' Ending Cash Position of $0.07 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Healthcare Providers & Services company?
A good Ending Cash Position depends on the Healthcare Providers & Services industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on FOXO Technologies and its competitors. FOXO Technologies's current Ending Cash Position is $0.07 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FOXO Technologies stock overvalued right now?
FOXO Technologies (FOXOD) has a current Ending Cash Position of $0.07 Mil. The current Ending Cash Position is $0.07 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For FOXO Technologies (FOXOD), the current Ending Cash Position is $0.07 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FOXO Technologies Business Description

Address 477 South Rosemary Avenue, Suite 224, West Palm Beach, FL, USA, 33401
FOXO Technologies Inc is a healthcare services and technology company. It currently operates four synergistic divisions: (i) a rural hospital division; (ii) a mental and behavioral health division; (iii) an information, data and biospecimen sourcing division; and (iv) an epigenetics diagnostics and interpretation division. The Company manages and classifies its business into three reportable business segments: (i) Healthcare, (ii) Life Science Services and (iii) Labs. Myrtle, RCHI and SCCH operate under the Healthcare segment and Vector operates under the Life Science Services segment. The company generates majority of its revenue from Healthcare segment. It includes RCHI's hospital, BSF, has 25 inpatient beds, and a 24/7 emergency department and provides ancillary services.